Following 27 months of AKT inhibition, RECISTv1.1 progressive disease was confirmed on restaging PET-CT imaging, showing an increase in the size of multifocal pulmonary metastases and increase in left axillary nodal metastatic disease. This evidence concerns the gene AKT1 and metastatic neoplasm.